366 related articles for article (PubMed ID: 27632639)
21. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
[TBL] [Abstract][Full Text] [Related]
22. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
23. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
Chen Y; Zhang Y; He J; Fu Y; Lin C; Li X
Oncol Rep; 2017 Mar; 37(3):1646-1652. PubMed ID: 28098895
[TBL] [Abstract][Full Text] [Related]
25. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Ling H; Pickard K; Ivan C; Isella C; Ikuo M; Mitter R; Spizzo R; Bullock M; Braicu C; Pileczki V; Vincent K; Pichler M; Stiegelbauer V; Hoefler G; Almeida MI; Hsiao A; Zhang X; Primrose J; Packham G; Liu K; Bojja K; Gafà R; Xiao L; Rossi S; Song JH; Vannini I; Fanini F; Kopetz S; Zweidler-McKay P; Wang X; Ionescu C; Irimie A; Fabbri M; Lanza G; Hamilton SR; Berindan-Neagoe I; Medico E; Mirnezami A; Calin GA; Nicoloso MS
Gut; 2016 Jun; 65(6):977-989. PubMed ID: 25804630
[TBL] [Abstract][Full Text] [Related]
26. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
[TBL] [Abstract][Full Text] [Related]
28. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
Hao JP; Ma A
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
[TBL] [Abstract][Full Text] [Related]
29. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
[TBL] [Abstract][Full Text] [Related]
30. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
[TBL] [Abstract][Full Text] [Related]
31. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.
Slattery ML; Herrick JS; Mullany LE; Valeri N; Stevens J; Caan BJ; Samowitz W; Wolff RK
Int J Cancer; 2015 Jul; 137(2):428-38. PubMed ID: 25484364
[TBL] [Abstract][Full Text] [Related]
32. Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.
He D; Yue Z; Li G; Chen L; Feng H; Sun J
Med Sci Monit; 2018 Oct; 24():7475-7481. PubMed ID: 30341274
[TBL] [Abstract][Full Text] [Related]
33. MiR-320e is a novel prognostic biomarker in colorectal cancer.
Perez-Carbonell L; Sinicrope FA; Alberts SR; Oberg AL; Balaguer F; Castells A; Boland CR; Goel A
Br J Cancer; 2015 Jun; 113(1):83-90. PubMed ID: 26035698
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.
Kijima T; Hazama S; Tsunedomi R; Tanaka H; Takenouchi H; Kanekiyo S; Inoue Y; Nakashima M; Iida M; Sakamoto K; Suzuki N; Takeda S; Ueno T; Yamamoto S; Yoshino S; Okuno K; Nagano H
Oncol Rep; 2017 Jan; 37(1):23-30. PubMed ID: 27878288
[TBL] [Abstract][Full Text] [Related]
35. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Wang LG; Gu J
Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950
[TBL] [Abstract][Full Text] [Related]
36. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363
[TBL] [Abstract][Full Text] [Related]
37. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
Madhavan D; Peng C; Wallwiener M; Zucknick M; Nees J; Schott S; Rudolph A; Riethdorf S; Trumpp A; Pantel K; Sohn C; Chang-Claude J; Schneeweiss A; Burwinkel B
Carcinogenesis; 2016 May; 37(5):461-70. PubMed ID: 26785733
[TBL] [Abstract][Full Text] [Related]
38. Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.
Basati G; Razavi AE; Pakzad I; Malayeri FA
Tumour Biol; 2016 Feb; 37(2):1781-8. PubMed ID: 26318304
[TBL] [Abstract][Full Text] [Related]
39. Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
Yuan Z; Baker K; Redman MW; Wang L; Adams SV; Yu M; Dickinson B; Makar K; Ulrich N; Böhm J; Wurscher M; Westerhoff M; Medwell S; Moonka R; Sinanan M; Fichera A; Vickers K; Grady WM
Br J Cancer; 2017 Oct; 117(8):1202-1210. PubMed ID: 28809863
[TBL] [Abstract][Full Text] [Related]
40. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
